Previously in our study, we demonstrated that changes in serum concentrations of MMP-9 in patients with NSCLC during chemotherapy were intimately associated with chemotherapy outcome [12], which was in accordance with a previous study in colorectal cancer [24]. The gene discussed is MMP9; the disease is colorectal cancer.